[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Fuster et al., 2008 - Google Patents

Preoperative staging of large primary breast cancer with [18F] fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional …

Fuster et al., 2008

View PDF
Document ID
13355680465162974719
Author
Fuster D
Duch J
Paredes P
Velasco M
Munoz M
Santamaría G
Fontanillas M
Pons F
Publication year
Publication venue
Journal of Clinical Oncology

External Links

Snippet

Purpose To evaluate the utility of positron emission tomography (PET) and [18F] fluorodeoxyglucose in the initial staging of large primary breast tumors. Patients and Methods This prospective study was approved by the ethics committee, and all patients gave …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/32Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
    • G06F19/321Management of medical image data, e.g. communication or archiving systems such as picture archiving and communication systems [PACS] or related medical protocols such as digital imaging and communications in medicine protocol [DICOM]; Editing of medical image data, e.g. adding diagnosis information
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/50Clinical applications
    • A61B6/507Clinical applications involving determination of haemodynamic parameters, e.g. perfusion CT
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/50Clinical applications
    • A61B6/502Clinical applications involving diagnosis of breast, i.e. mammography
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/02Devices for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03Computerised tomographs
    • A61B6/032Transmission computed tomography [CT]
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00Indexing scheme for image analysis or image enhancement
    • G06T2207/10Image acquisition modality
    • G06T2207/10072Tomographic images
    • G06T2207/10084Hybrid tomography; Concurrent acquisition with multiple different tomographic modalities
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/0493Steroids, e.g. cholesterol, testosterone

Similar Documents

Publication Publication Date Title
Fuster et al. Preoperative staging of large primary breast cancer with [18F] fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures
Ruers et al. Value of positron emission tomography with [F-18] fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study
Ng et al. Prospective study of [18F] fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck
Meltzer et al. Whole-body FDG positron emission tomographic imaging for staging esophageal cancer: comparison with computed tomography
Motosugi et al. Detection of pancreatic carcinoma and liver metastases with Gadoxetic acid–enhanced MR imaging: comparison with contrast-enhanced multi–detector row CT
Morris et al. Integrated positron emission tomography/computed tomography may render bone scintigraphy unnecessary to investigate suspected metastatic breast cancer
Eubank et al. Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrent or metastatic breast cancer
Drieskens et al. FDG-PET for preoperative staging of bladder cancer
Reinhardt et al. Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N-and M-staging of malignant melanoma: experience with 250 consecutive patients
Yoon et al. CT, MR, US, 18 F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck
Antoch et al. Accuracy of whole-body dual-modality fluorine-18–2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET
Heriot et al. Does positron emission tomography change management in primary rectal cancer? A prospective assessment
Nakamoto et al. Delayed 18F‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas
Bar-Shalom et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management
Jeong et al. Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis?
Schilling et al. Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging
Choi et al. Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging
Kulinna et al. Staging of rectal cancer: diagnostic potential of multiplanar reconstructions with MDCT
Takanami et al. Additional value of FDG PET/CT to contrast-enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules
Chen et al. Comparison of 18F-Fluciclovine PET/CT and 99mTc-MDP bone scan in detection of bone metastasis in prostate cancer
Weir et al. The value of FDG positron emission tomography in the management of patients with breast cancer
Pfluger et al. PET/CT in malignant melanoma: contrast-enhanced CT versus plain low-dose CT
Kwak et al. Diagnostic value of FDG-PET/CT for lymph node metastasis of colorectal cancer
Veit-Haibach et al. FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy
Litmanovich et al. Unexpected foci of 18 F-FDG uptake in the breast detected by PET/CT: incidence and clinical significance